Trial Profile
Effects of High-dose Coenzyme Q10 on Biomarkers of Oxidative Damage and Clinical Outcome in Parkinson Disease
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Ubidecarenone (Primary)
- Indications Parkinson's disease
- Focus Biomarker; Pharmacodynamics
- 24 Aug 2013 New trial record